Skip to main content
NIH funding notice RFA-NS-24-003

Assessment of TBI-related ADRD Pathology Related to Cognitive Impairment and Dementia Outcomes (U01 - Clinical Trial Not Allowed)

Closed on July 28, 2023.

Posted
May 19, 2023
Close date
July 28, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,350,002 in first-year total cost, median $1,756,811.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-O (26)]3

Most frequent institutions

  1. BOSTON UNIVERSITY MEDICAL CAMPUS1
  2. UNIVERSITY OF PENNSYLVANIA1
  3. UNIVERSITY OF WASHINGTON1
Competing awards under RFA-NS-24-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Transdisciplinary Research Accelerating Neuropathology Studies and Facilitating Open Research Methods in TBI (TRANSFORM-TBI)1U01NS137500-01LEE, EDWARD BYUNG-HASMITH, DOUGLAS HAMILTONSTEWART, WILLIAMUNIVERSITY OF PENNSYLVANIA, PA$2,032,044ZNS1
2024Neuroimaging and clinical Endpoints With High-dimensional analysis Of Pathological Endophenotypes in TBI (NEW-HOPE-TBI)1U01NS137484-01KEENE, CHRISTOPHER DIRKUNIVERSITY OF WASHINGTON, WA$1,756,811ZNS1
2024Contributions of Brain Trauma to AD/ADRD Neuropathology, including CTE, and Resulting Clinical Outcomes1U01NS137483-01MCKEE, ANN C.BOSTON UNIVERSITY MEDICAL CAMPUS, MA$561,147ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-NS-24-003: Assessment of TBI-related ADRD Pathology Related to Cognitive Impairment and Dementia Outcomes (U01 - Clinical Trial Not Allowed) | ScienceDex | ConductScience